Ian Peikon
InvestorFounderVenture Partner at Lux Capital · Co-Founder and Co-Chief Executive Officer at Cajal Therapeutics · Co-Founder and Co-Chief Executive Officer at Cajalneuro
New York, New York
Writes $1M – $50M checks · typically $10M
FoundedCajal TherapeuticsCajalneuro
Find your path to Ian
242 people in our graph share verified history with Ian — schools, employers, funds. One of them is your warm intro.
Stacey HerounlockedIan: together at Duke University (2005)
×10Ian: together at Lux Capital
Ian: together at Kallyope
About
Ian Peikon is co-founder and co-chief executive officer of Cajal Therapeutics. He brings experience in team leadership and scientific research, with background in molecular biology, neuroscience, and biomedical engineering.
Co-Founder and Co-Chief Executive Officer at Cajal Therapeutics
Intro paths
→
In turn, Ian can intro founders to Cajal Therapeutics's investors below.
Cajal Therapeutics's investors · 1
Co-founders at Cajal Therapeutics
AD
Andrew DervanCo-Founder and Co-Chief Executive Officer
RH
Rob HershbergCo-Founder and Executive Chairman
Co-Founder and Co-Chief Executive Officer at Cajalneuro
Intro paths
→
In turn, Ian can intro founders to Cajalneuro's investors below.
Cajalneuro's investors · 2
Co-founders at Cajalneuro
AD
Andrew DervanCo-Founder and Co-Chief Executive Officer
RH
Rob HershbergCo-Founder and Executive Chairman
Experience
- Cajal TherapeuticsCo-Founder & Co-Chief Executive Officercurrent2020 — present
- Lux CapitalVenture Partnercurrent2019 — presentGreater New York City Area
- Cold Spring Harbor Laboratory Library and ArchivesAdvisory Board Membercurrent2024 — presentCold Spring Harbor, New York, United States
- PlexiumBoard Member2022 — 2025
- VNV BioCo-Founder & SAB Member2018 — 2022Greater New York City Area
- KallyopeCo-Founder & Director, Platform Biology & Technology2015 — 2019
Skills & more
Molecular Biology19Neuroscience12Biotechnology2Start-ups1Biomedical Engineering10Electrophysiology8Fluorescence Microscopy19Confocal Microscopy16Genetics8Matlab8Cell Biology10C++4
+8 more
Computational BiologyBioinformaticsSynthetic BiologyProtein PurificationWestern BlottingPCREmulsion PCRCell CultureFrom Ian's professional profile.
Colleagues at Lux Capital
Adam Goulburn
Investor at Lux Capital
Adam Kalish
Partner, Capital Formation at Lux Capital
Ale Salardi
Executive Assistant at Lux Capital
Andrew Wilson
Partner, Legal at Lux Capital
Barkha Gvalani
Special Partner at Renegade Partners
Bibi Masara
Office Manager at Lux Capital
Brad Gritsch
Finance at Lux Capital
Brandon Reeves
Partner at Lux Capital
Network7
Alex Nguyen
Partner at Lux Capital
Bilal Zuberi
Founder and Managing Partner at Red Glass Ventures
Brandon Reeves
Partner at Lux Capital
Danny Crichton
Partner, Research at Lux Capital, publishing the Securities newsletter and Riskgaming
David Yang
Partner at Lux Capital
Deena Shakir
Partner at Lux Capital
Tess van Stekelenburg
Partner at Lux Capital
Investors connected to Ian in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Ian Peikon?
- Ian Peikon is co-founder and co-chief executive officer of Cajal Therapeutics. He brings experience in team leadership and scientific research, with background in molecular biology, neuroscience, and biomedical engineering.
- Where does Ian Peikon work?
- Ian Peikon is Co-Founder and Co-Chief Executive Officer of Cajal Therapeutics and Venture Partner at Lux Capital and Co-Founder and Co-Chief Executive Officer at Cajalneuro.
- What check size does Ian Peikon write?
- Ian Peikon typically writes checks of $1M – $50M.
- What companies did Ian Peikon found?
- Ian Peikon founded Cajal Therapeutics, Cajalneuro.
- Where did Ian Peikon go to school?
- Ian Peikon studied at Cold Spring Harbor Laboratory (PhD, Biological Sciences); Duke University (BSE, Biomedical Engineering).
Founder mafias
Duke University mafia288
Also came through, then founded or led a company.
Marc AndreessenBachelor of Arts (B.A.)Founded OpswareFred EhrsamB.S.Founded Nudge +1Zach PerretBSFounded PlaidDavid CummingsBSFounded Undaunted +6George ChurchBachelor's degreeFounded Editas Medicine +5Romesh SubramanianM.S.Founded RaNA Therapeutics +2
+ 281 more
Lux Capital mafia11
Also came through, then founded or led a company.
Alex Wright-GladsteinInternFounded Sphere +1Josh WolfeCo-FounderFounded Genocea BiosciencesTess van StekelenburgPartnerFounded ValthosMichelle FangResidentFounded Cerebras SystemsCatie YoungExecutive AssistantFounded SolanaAdam GoulburnVenture PartnerFounded Kallyope
+ 4 more
Kallyope mafia6
Also came through, then founded or led a company.
Cold Spring Harbor Laboratory mafia4
Also came through, then founded or led a company.
Cajal Therapeutics mafia2
Also came through, then founded or led a company.
Same school
Also attended Cold Spring Harbor Laboratory9
Stella PaffenholzSenior Associate at Atlas VentureMichael GutbrodSenior Associate at Sante VenturesTim Van TreurenPrincipal of New Ventures at Bios PartnersTim Van Treuren, PhDCompanies Seeking Investment at Bios PartnersCasper VroemenChief R&D Officer, Global at IFF at The Innovation SpaceOriane HedinCFO at Galion.exe
+ 3 more
Also attended Duke University825
Marc AndreessenCo-founder & General Partner at Andreessen HorowitzFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpAyaan PatelInvestor at Lightbank
+ 819 more
Shared employers
Also worked at Cajal Therapeutics1
Also worked at Plexium11
Therese LiechtensteinPartner at 4BIO CapitalKiersten SteadManaging Partner, DCVC Bio at DCVC (Data Collective)Rob HopfnerManaging Director at Pivotal Life SciencesBenjamin LiVice President at Pivotal Life SciencesJohn CassidyPartner, EMEA at SoftBank Vision FundJoey MasonLife Sciences Venture Partner at Claret Capital Partners
+ 5 more
Also worked at Kallyope7
Josh WolfePartner and Co-Founder at Lux CapitalRami HannoushVenture Partner at Versant VenturesJeff GoaterPartner at The Column GroupDusan PerovicPartner at Two Sigma VenturesAdam GoulburnFounder and Managing Partner at Dimension CapitalMayank AgrawalFounder at Proof of Human
+ 1 more